Exploitation of alternative skin models from academia to industry: proposed functional categories to answer needs and regulation demands
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
OPINION article Front. Physiol., 02 June 2023Sec. Skin Physiology Volume 14 - 2023 | https://doi.org/10.3389/fphys.2023.1215266
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ASM like reconstructed skin, organ on a chip, ex vivo skin, and different computational models hold more promising applications than the animal models (138).”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [138]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The use of alternative skin models (ASM) for testing purposes attracted the attention of both industries and academia. The ASM development is now considered crucial in the field of dermatology as animal models studies are time consuming, costly, react differently compared to human skin, and issues of ethical concerns.”
From The dark side of beauty: an in-depth analysis of the health hazards and toxicological impact of synthetic cosmetics and personal care products (2024) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589 · cited 1×
“For example, the database obtained from models that mimic the skin environment could be used to study skin diseases and develop new treatments, including personalized medicine approaches (Ingber, 2022).”
BackgroundIntrinsic and extrinsic factors in skin ageing: a review
Farage, M. A., Miller, K. W., Elsner, P., & Maibach, H. I. (2008) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2007.00415.x · Cited by 950 · cited 1×
“Models for environmental stressors can be used to prove protection efficacy by comparing damage markers before and after treatment (Farage et al., 2008; Portugal-Cohen et al., 2009).”
BackgroundRegulation (EC) No 764/2008 of the European Parliament and of the Council
Smith, R. (2015) · Core EU Legislation · doi:10.1007/978-1-137-54482-7_19 · Cited by 465 · cited 1×
“In cosmetics, animal testing has been banned in the European Union and several other countries since 2013 (UNION, 2009).”
BackgroundViceconti, M., Pappalardo, F., Rodriguez, B., Horner, M., Bischoff, J., & Musuamba Tshinanu, F. (2021) · Methods · doi:10.1016/j.ymeth.2020.01.011 · Cited by 361 · cited 1×
“In vitro and in silico models have been developed to assess the safety of these chemicals before human testing (Viceconti et al., 2021).”
BackgroundThe use of skin models in drug development
Mathes, S. H., Ruffner, H., & Graf-Hausner, U. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.006 · Cited by 318 · cited 4×
“In the field of dermatology, the development of ASM has become crucial (Mathes et al., 2014; Yun et al., 2018).”
BackgroundInfluentialPumpless microfluidic platform for drug testing on human skin equivalents
Abaci, H. E., Gledhill, K., Guo, Z., Christiano, A. M., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c4lc00999a · Cited by 262
Yuspa, S. H. (1994) · PubMed · Cited by 255
Niehues, H., Bouwstra, J. A., El Ghalbzouri, A., Brandner, J. M., Zeeuwen, P. L. J. M., & van den Bogaard, E. H. (2018) · Experimental Dermatology · doi:10.1111/exd.13531 · Cited by 210 · cited 2×
“, 2022) systemically acting drugs applied on the skin; (Niehues et al., 2018) drugs acting at the site of application in the case of skin diseases or disorders.”
BackgroundAdvances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models
Randall, M. J., Jüngel, A., Rimann, M., & Wuertz-Kozak, K. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00154 · Cited by 194 · cited 1×
“They are created by combining different cell types, such as keratinocytes, fibroblasts, and melanocytes, in a three-dimensional structure; hence, different application types can be tested (Randall et al., 2018).”
BackgroundLimitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2020) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.010 · Cited by 186
Sierra-Sánchez, Á., Kim, K. H., Blasco‐Morente, G., & Arias‐Santiago, S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00144-0 · Cited by 160 · cited 1×
“These models could also be used to develop skin substitutes for patients with severe burns or other skin injuries (Sierra-Sánchez et al., 2021).”
BackgroundSkin-on-a-chip models: General overview and future perspectives
Risueño, I., Valencia, L., Jorcano, J. L., & Velasco, D. (2021) · APL Bioengineering · doi:10.1063/5.0046376 · Cited by 137 · cited 1×
“The chamber is connected to channels that allow for the flow of nutrients, oxygen, and other factors to capture the complex interactions between the skin and other organs or systems in the body, such as the immune system or the nervous system (Risueño Rojo et al., 2021).”
BackgroundModels in the Research Process of Psoriasis
Bocheńska, K., Smolińska, E., Moskot, M., Jakóbkiewicz-Banecka, J., & Gabig-Cimińska, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122514 · Cited by 132 · cited 1×
“, wound healing (Greenhalgh, 2005), aging (Giacomoni and Rein, 2004), psoriasis (Bocheńska et al., 2017), atopic dermatitis (Eyerich et al.”
BackgroundGötz, C., Pfeiffer, R., Tigges, J., Ruwiedel, K., Hübenthal, U., Merk, H. F., Krutmann, J., Edwards, R. J., Abel, J., Pease, C., et al. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01478.x · Cited by 130 · cited 1×
“Since these are not regulated, there is a high degree of freedom and creativity in selecting the models and assays (Götz et al., 2012; Zappelli et al., 2016; Filaire et al., 2022).”
BackgroundGreenhalgh, D. G. (2005) · Journal of Burn Care & Rehabilitation · doi:10.1097/01.bcr.0000169885.66639.b5 · Cited by 114 · cited 2×
“Part of these models has been used widely for years in both basic research and industrial sectors, e.g., wound healing (Greenhalgh, 2005), aging (Giacomoni and Rein, 2004), psoriasis (Bocheńska et al., 2017), atopic dermatitis (Eyerich et al., 2019), acne (Kanwar et al., 2018), and SCC (Yuspa,…”
BackgroundMethodEngineered Skin Tissue Equivalents for Product Evaluation and Therapeutic Applications
Suhail, S., Sardashti, N., Jaiswal, D., Rudraiah, S., Misra, M., & Kumbar, S. G. (2019) · Biotechnology Journal · doi:10.1002/biot.201900022 · Cited by 91 · cited 1×
“) for designated treatment development (Suhail et al., 2019).”
Regulation (EC) No 864/2007 of the European Parliament and of the Council
(2016) · Hart Publishing eBooks · doi:10.5040/9781782258674.0005 · Cited by 91
Eyerich, K., Brown, S., White, B. E. P., Tanaka, R. J., Bissonette, R., Dhar, S., Bieber, T. R. M., Hijnen, D., Guttman‐Yassky, E., Irvine, A. D., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.033 · Cited by 87
Skin organoids: a new human model for developmental and translational research
Lee, J., & Koehler, K. R. (2021) · Experimental Dermatology · doi:10.1111/exd.14292 · Cited by 85 · cited 3×
“, 2020), and skin organoid cultures, made by growing skin tissue in culture under conditions that mimic the in vivo environment, like basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) (Lee and Koehler, 2021).”
BackgroundIn vitro cultured human skin cells as alternatives to animals for skin irritancy screening
PONEC, M. (1992) · International Journal of Cosmetic Science · doi:10.1111/j.1467-2494.1992.tb00058.x · Cited by 79 · cited 1×
“They are appropriate for mechanism elucidation and certain factor isolation for initial proof of concept in dermatology (Ponec, 1992).”
BackgroundModels for acne: A comprehensive study
Kanwar, I. L., Haider, T., Kumari, A., Dubey, S., Jain, P., & Soni, V. (2018) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2018.01079 · Cited by 72 · cited 1×
“, 2019), acne (Kanwar et al., 2018), and SCC (Yuspa, 1994), while part of them are less common, e.”
BackgroundKim, J. J., Ellett, F., Thomas, C. N., Jalali, F., Anderson, R. R., Irimia, D., & Raff, A. B. (2019) · Lab on a Chip · doi:10.1039/c9lc00399a · Cited by 69
Eberlin, S., Silva, M. S. D., Facchini, G., Silva, G. H. D., Pinheiro, A. L. T. A., Eberlin, S., & Pinheiro, A. D. S. (2020) · Alternatives to Laboratory Animals · doi:10.1177/0261192920914193 · Cited by 69 · cited 1×
“Examples of ex vivo human skin models are skin explants, made by taking a small piece of skin tissue from a donor and maintaining it in culture (Eberlin et al., 2020), and skin organoid cultures, made by growing skin tissue in culture under conditions that mimic the in vivo environment, like basal cell carcinoma (BCC)…”
BackgroundNew developments in the molecular treatment of ichthyosis: review of the literature
Joosten, M. D. W., Clabbers, J. M. K., Jonca, N., Mazereeuw‐Hautier, J., & Gostyński, A. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02430-6 · Cited by 69
Artificial skin models for animal-free testing
Yun, Y. E., Jung, Y. J., Choi, Y. J., Choi, J. S., & Cho, Y. W. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-0389-1 · Cited by 67 · cited 1×
“In the field of dermatology, the development of ASM has become crucial (Mathes et al., 2014; Yun et al., 2018).”
BackgroundAlternative in vitro models used in the main safety tests of cosmetic products and new challenges
Filaire, E., Nachat, R., Camille, L., Harmand, M., Simon, M., & Poinsot, C. (2022) · International Journal of Cosmetic Science · doi:10.1111/ics.12803 · Cited by 67
Lukács, B., Bajza, Á., Kocsis, D., Csorba, A., Antal, I., Iván, K., Laki, A. J., & Erdő, F. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11090445 · Cited by 66
Pena, A., Chen, X., Pence, I. J., Bornschlögl, T., Jeong, S., Grégoire, S., Luengo, G. S., Hallegot, P., Obeidy, P., Feizpour, A., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.03.003 · Cited by 66 · cited 1×
“Novel 3D models allow absorption and distribution studies of test materials in skin throughmethods such as fluorescence labeling (Pena et al., 2020).”
BackgroundSilva, R. J., & Tamburic, S. (2022) · Cosmetics · doi:10.3390/cosmetics9050090 · Cited by 63
Bas, A., Burns, N., Gulotta, A., Junker, J., Drasler, B., Lehner, R., Aicher, L., Constant, S., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2021) · Small · doi:10.1002/smll.202006027 · Cited by 60 · cited 1×
“More research is needed to streamline the validation process and to ensure that ASM can replace traditional animal testing methods (Bas et al., 2021).”
MethodTheocharidis, G., Tekkela, S., Veves, A., McGrath, J. A., & Onoufriadis, A. (2022) · Experimental Dermatology · doi:10.1111/exd.14547 · Cited by 59
Protective effects of a cream containing Dead Sea minerals against UVB‐induced stress in human skin
Portugal-Cohen, M., Soroka, Y., Ma'or, Z., Oron, M., Zioni, T., Brégégère, F., Neuman, R., Kohen, R., & Milner, Y. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00865.x · Cited by 58 · cited 1×
“Models for environmental stressors can be used to prove protection efficacy by comparing damage markers before and after treatment (Farage et al., 2008; Portugal-Cohen et al., 2009).”
BackgroundAlternative methods in toxicity testing: the current approach
Araújo, G. L. D., Campos, M. A. A., Valente, M. A. S., Silva, S. C. T., França, F. D., Chaves, M. M., & Tagliati, C. A. (2014) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502011000100005 · Cited by 58 · cited 2×
“1970s Surgical waste or discarded skin Developed for medical research to study skin diseases and drug and cosmetic effects (Araújo et al., 2014).”
BackgroundPortugal‐Cohen, M., Soroka, Y., Frušić‐Zlotkin, M., Verkhovsky, L., Brégégère, F. M., Neuman, R., Kohen, R., & Milner, Y. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01317.x · Cited by 57 · cited 1×
“Ultraviolet (UV) radiation is a major contributor to skin damage, including premature aging, hyperpigmentation, and skin cancer (Portugal-Cohen et al., 2011).”
BackgroundA mechanistic model for the aging of human skin
Giacomoni, P. U., & Rein, G. (2003) · Micron · doi:10.1016/j.micron.2003.11.004 · Cited by 52 · cited 1×
“, wound healing (Greenhalgh, 2005), aging (Giacomoni and Rein, 2004), psoriasis (Bocheńska et al.”
BackgroundSkinEthic™ RHE for in vitro evaluation of skin irritation of medical device extracts
Pellevoisin, C., Videau, C., Briotet, D., Grégoire, C., Tornier, C., Alonso, A., Rigaudeau, A. S., Bouez, C., & Seyler, N. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.01.008 · Cited by 52
helen, F. J., Malcomber, I., Maxwell, G., & Westmoreland, C. (2021) · Alternatives to Laboratory Animals · doi:10.1177/02611929211040824 · Cited by 51 · cited 1×
“The ECHA requires the use of alternative methods to animal testing for registration of chemicals under the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulation (Fentem et al., 2021).”
MethodEffective Active Ingredients Obtained through Biotechnology
Zappelli, C., Barbulova, A., Apone, F., & Colucci, G. (2016) · Cosmetics · doi:10.3390/cosmetics3040039 · Cited by 50
In vitro human skin irritation test for evaluation of medical device extracts
Casas, J., Lewerenz, G. M., Rankin, E. A., Willoughby, J. A., Blakeman, L. C., McKim, J. M., & Coleman, K. P. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.08.006 · Cited by 45 · cited 2×
“Since early 2010s 3D-reconstructed skin models, ex vivo models Medical device research and development, mainly for biocompatibility tests (Casas et al., 2013; Wang et al., 2021).”
BackgroundGueniche, A., Perin, O., Bouslimani, A., Landemaine, L., Misra, N., Cupferman, S., Aguilar, L., Clavaud, C., Chopra, T., & Khodr, A. (2022) · Pathogens · doi:10.3390/pathogens11020121 · Cited by 44
Antipollution skin protection – a new paradigm and its demonstration on two active compounds
Portugal‐Cohen, M., Oron, M., Cohen, D., & Ma’or, Z. (2017) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s129437 · Cited by 41
Danilenko, D. M., Phillips, G. D. L., & Diaz, D. (2016) · Toxicologic Pathology · doi:10.1177/0192623316632074 · Cited by 40 · cited 1×
“ASM, based on human cells, reconstructed skin, ex vivo skin, organ-on-a-chip, and computational in silico models, have emerged as a promising solution, as they are more cost-effective and sustainable, present fewer ethical considerations, and, in certain cases, show advantages compared to the corresponding animal mode…”
BackgroundThe Importance of the Prediction Model in the Validation of Alternative Tests
Worth, A. P., & Balls, M. (2001) · Alternatives to Laboratory Animals · doi:10.1177/026119290102900210 · Cited by 40 · cited 1×
“Currently, the validation process for these models can be complex and expensive (Worth and Balls, 2001), which has been a barrier to their adoption.”
BackgroundHayden, P. J., Bachelor, M. A., Ayehunie, S., Letašiová, S., Kaluzhny, Y., Klausner, M., & Kanďárová, H. (2015) · Applied In Vitro Toxicology · doi:10.1089/aivt.2015.0012 · Cited by 32 · cited 2×
“1980s and 1990s 3D-reconstructed skin model adoption Cosmetic and personal care industry for safety and efficacy testing of new products, reducing the need for animal testing (Hayden et al., 2015).”
BackgroundAn ex vivo model of medical device-mediated bacterial skin translocation
Wang, H., Agrawal, A., Wang, Y. N., Crawford, D. W., Siler, Z., Peterson, M. L., Woofter, R. T., Labib, M. E., Shin, H. Y., Baumann, A. P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84826-1 · Cited by 30 · cited 2×
“Since early 2010s 3D-reconstructed skin models, ex vivo models Medical device research and development, mainly for biocompatibility tests (Casas et al., 2013; Wang et al., 2021).”
BackgroundDesign of In Vitro Hair Follicles for Different Applications in the Treatment of Alopecia—A Review
Žnidarič, M., Žurga, Ž. M., & Maver, U. (2021) · Biomedicines · doi:10.3390/biomedicines9040435 · Cited by 28 · cited 1×
“, 2021), alopecia (Žnidarič et al., 2021), and ichthyosis (Joosten et al.”
BackgroundVinken, M. (2020) · EXCLI journal · doi:10.17179/excli2020-1463 · Cited by 27 · cited 1×
“RHS and ex vivo explants are useful models for dermal and sub-cutaneous distributions (Vinken, 2020).”
Popular over‐the‐counter cosmeceutical ingredients and their clinical efficacy
Tetali, B., Fahs, F., & Mehregan, D. R. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14718 · Cited by 25 · cited 2×
“Skin-on-a-chip provides the infrastructure for complex interactions between the skin and other organs or systems (Tetali et al., 2020).”
BackgroundMorales, M., Pérez, D., Correa, L., & Múnera, L. M. R. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.07.010 · Cited by 23 · cited 1×
“The European Centre for the Validation of Alternative Methods (ECVAM) has developed and validated several ASM, including reconstructed human skin models, which are widely used in the cosmetics industry, for example, OECD guidelines for testing chemicals for skin corrosion or irritation (OECD/OCDE 431/ 439) (Morales et…”
MethodRon‐Doitch, S., Soroka, Y., Frušić‐Zlotkin, M., Barasch, D., Steinberg, D., & Kohen, R. (2020) · Experimental Dermatology · doi:10.1111/exd.14103 · Cited by 18
Modeling Skin Inflammation Using Human In Vitro Models
Boarder, E., Rumberger, B., & Howell, M. D. (2021) · Current Protocols · doi:10.1002/cpz1.72 · Cited by 13
Ates, G., Raitano, G., Heymans, A., Bossuyt, M. V., Vanparys, P., Mertens, B., Chesné, C., Roncaglioni, A., Milushev, D., Benfenati, E., et al. (2016) · Mutagenesis · doi:10.1093/mutage/gew008 · Cited by 12
dos Santos, C. E. M., Miranda, R. G., de Oliveira, D. P., & Dorta, D. J. (2020) · Water · doi:10.3390/w12123549 · Cited by 12
Ron‐Doitch, S., Frušić‐Zlotkin, M., Soroka, Y., Duanis‐Assaf, D., Amar, D., Kohen, R., & Steinberg, D. (2021) · Microorganisms · doi:10.3390/microorganisms9040788 · Cited by 8
Harmonisation of Animal Testing Alternatives in China
Cheng, S., Qu, X., & Qin, Y. (2017) · Alternatives to Laboratory Animals · doi:10.1177/026119291704500603 · Cited by 6 · cited 1×
“This is mainly due to regulatory issues; for instance, the Asian market is quite demanding on this issue, accepting either only clinical studies or, in some cases, animal testing (Cheng et al., 2017).”
BackgroundSonawane, A., Vadloori, B., Poosala, S., Kanďárová, H., Kulkarni, M., Olayanju, A., Dey, T., Saxena, U., Smirnova, L., Kanda, Y., et al. (2022) · Alternatives to Laboratory Animals · doi:10.1177/02611929221089216 · Cited by 5 · cited 2×
“For drug development, these tissue models may be of particular interest for (Sonawane et al., 2022) systemically acting drugs applied on the skin; (Niehues et al.”
BackgroundMehling, A., Kolle, S. N., Wareing, B., & Landsiedel, R. (2022) · Cosmetics · doi:10.3390/cosmetics9010022 · Cited by 2 · cited 2×
“The transformation of ASM from research to industry has been slow but steady, as summarized in Table 1 (Casas et al., 2013; Araújo et al., 2014; Mathes et al., 2014; Abaci et al., 2015; Hayden et al., 2015; Lukács et al., 2019; Wang et al., 2021; Mehling et al., 2022; Silva and Tamburic, 2022).”
Background
Research works printed but not linked: 2
- 2013, Test No. 439: Vitro skin irritation-reconstructed human epidermis test method
- Lincoln, 2012, Overview of the us fda gmps: Good manufacturing practice (gmp)/quality system (qs) regulation (21 CFR part 820), J. validation Technol., 18, 17
Cited by
Sanjarnia, P., Picchio, M. L., Solis, A. N. P., Schuhladen, K., Fliss, P. M., Πολιτάκος, Ν., Metterhausen, L., Calderón, M., & Osorio‐Blanco, E. R. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115217 · Cited by 93
Alnuqaydan, A. M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1439027 · Cited by 84
Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
Alves, N. S. D., Reigado, G. R., Santos, M., Caldeira, I. D. S., Hernandes, H. D. S., Freitas, B. L., Zhivov, E. V., Chambergo, F. S., & Nunes, V. A. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1527854 · Cited by 71
Bhar, B., Das, E., Manikumar, K., & Mandal, B. B. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303312 · Cited by 47
In vitro 3D skin culture and its sustainability in toxicology: a narrative review
Masri, S., Fauzi, M. B., Rajab, N. F., Lee, W.-H., Zainal Abidin, D. A., & Siew, E. L. (2024) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2024.2407617 · Cited by 15
“…safer products and regulatory decisions aimed at protecting human health. commercial tissue manufacturing standardization, international validation and regulatory approval have led to the widespread usage of 3D reconstructed human skin models in industrial and academic research labs worldwide [62].”
Metadata
- Authors
- Portugal-Cohen, M., Cohen, D., Kohen, R., & Oron, M.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2023-06-02
- Volume
- 14
- Pages
- 1215266-1215266
- ISSN
- 1664-042X (ISSN-L)
- PMC
- PMC10272927
- OpenAlex
- W4379231920
- Cited by
- 24
- References
- 57
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 6 · 2023: 2
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Physiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- skin substitutes, skin physiology, functional categories, regulatory requirements, university-industry collaboration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
